🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a long-term follow-up of participants from the randomized con...
Status
Not Yet Recruiting
Location
Medical University of Warsaw
Start Date
2025-08
Trial ID
NCT07107451
Treatments Being Tested
The main purpose of this trial is to investigate if any of three different ...
Status
Completed
Location
Cetero Research
Start Date
2009-09
Trial ID
NCT00987909
Specific immunotherapy with recombinant birch pollen allergen rBet v1-FV...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2003-07
Trial ID
NCT00266526
Treatments Being Tested
The trial is performed to assess efficacy and safety of Novo-Helisen Depot ...
Status
Completed
Location
Allergopharma GmbH & Co. KG
Start Date
2002-09
Trial ID
NCT00263549
Treatments Being Tested
The goal of this follow-up study is to learn about long-term patient surviv...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham (UAB) Hospital
Start Date
2023-04-21
Trial ID
NCT05714514
This study evaluates the effectiveness and safety of PollenVax, a subcutane...
Status
Recruiting
Location
Limited Liability Partnership "Medcenter-Rakhat"
Start Date
2026-05-01
Trial ID
NCT07563439
Evaluation of patch as specific immunotherapy in allergic patients...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00719511
Severity of allergic reactions are highly variable from one individual to a...
Status
Completed
Location
Hôpital Saint Joseph
Start Date
2017-06-13
Trial ID
NCT03219827
Treatments Being Tested
The aim of this clinical trial is to show safety and efficacy of the allerg...
Status
Completed
Location
Allergopharma Joachim Ganzer KG
Start Date
2005-06
Trial ID
NCT00263627
Treatments Being Tested
Allergen specific immunotherapy (SIT) is the only causative treatment of Ig...
Status
Completed
Location
Clinic for Dermatology University Hospital of Zurich
Start Date
2001-06
Trial ID
NCT00470457
Treatments Being Tested